Intrathecal baclofen treatment in dystonic cerebral palsy: A randomized clinical trial: The IDYS trial

BMC Pediatrics

Volumn 13, Issue 1, 2013, Pages

  Bonouvrié, Laura A ^a   Becher, Jules G ^a   Vles, Johannes S H ^b   Boeschoten, Karin ^a   Soudant, Dan ^b   de Groot, Vincent ^a   van Ouwerkerk, Willem J R ^a   Strijers, Rob L M ^a   Foncke, Elisabeth ^a   Geytenbeek, Joke ^a   van de Ven, Peter M ^a   Teernstra, Onno ^b   Vermeulen, R J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cerebral palsy; Dyskinesia; Dystonia; Goal attainment scaling; Intrathecal baclofen; Randomized controlled trial

Indexed keywords

BACLOFEN; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; BASAL GANGLION; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MEGADOSE; DRUG SAFETY; DYSTONIA; DYSTONIC CEREBRAL PALSY; DYSTONIC DISORDER; ELECTROMYOGRAPHY; FOLLOW UP; GOAL ATTAINMENT; GROSS MOTOR FUNCTION CLASSIFICATION SYSTEM; HOFFMANN REFLEX; HUMAN; IMPLANTABLE PUMP; INFUSION PUMP; INTRATHECAL PUMP; MULTICENTER STUDY; OUTCOME ASSESSMENT; PAIN; PATIENT COMFORT; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SLEEP DISORDERED BREATHING; SPASTICITY; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE; WHITE MATTER; WHITE MATTER LESION;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; BACLOFEN; BRAIN; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; DYSTONIA; ELECTROMYOGRAPHY; FOLLOW-UP STUDIES; GABA AGONISTS; GOALS; H-REFLEX; HUMANS; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, SPINAL; MAGNETIC RESONANCE IMAGING; MULTICENTER STUDIES AS TOPIC; MUSCLE SPASTICITY; PAIN MANAGEMENT; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SAMPLE SIZE; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, CENTRAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84886120687     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-13-175     Document Type: Article

References (38)

1. Hagberg B, Hagberg G, Olow I, von Wendt L. The changing panorama of cerebral palsy in Sweden. V. The birth year period 1979-82. Acta Paediatr Scand 1989, 78:283-290. 10.1111/j.1651-2227.1989.tb11071.x, 2784617.
2. Bax M, Goldstein M, Rosenbaum PL, Levinton A, Paneth N, Dan B, Jacobsson B, Damiano D. Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol 2005, 47:571-576. 10.1017/S001216220500112X, 16108461.
3. Krägeloh-Mann I, Helber A, Mader I, Staudt M, Wolff M, Groenendaal F, DeVries L. Bilateral lesions of thalamus and basal ganglia: origin and outcome. Dev Med Child Neurol 2002, 44:477-484.
4. Jankovic J. Treatment of hyperkinetic movement disorders. The Lancet Neurology 2009, 8:844-856.
5. Sanger TD, Bastian A, Brunstrom J, Damiano D, Delgado M, Dure L, Gaebler-Spira D, Hoon A, Mink JW, Sherman-Levine S, Wlty LJ. Child Motor Study Group. Prospective open-label clinical trial of trihexyphnidyl in children with secondary dystonia due to cerebral palsy. J Child Neurol 2007, 22:530-537. 10.1177/0883073807302601, 17690057.
6. Dan B, Motta F, Vles JS, Vloeberghs M, Becher JG, Eunson P, Gautheron V, Lutjen S, Mall V, Pascual-Pascual SI, Pauwels P, Roste GK. Consensus on the appropriate use of intrathecal baclofen (ITB) therapy in paediatric spasticity. Eur J Paediatr Neurol 2010, 14:19-28. 10.1016/j.ejpn.2009.05.002, 19541514.
7. van Hulst BM, Tel PA, de Groot V, van Ouwerkerk WJ, Vermeulen RJ, Becher JG, Peerdeman SM. Complicaties bij kinderen met intrathecale baclofentherapie en (gerelateerde) verzorgertevredenheid. Tijdschrift voor kindergeneeskunde 2009, 77:191-197.
8. Ward A, Hayden S, Dexter M, Scheinberg A. Continuous intrathecal baclofen for children with spasticity and/or dystonia: Goal attainment and complications associated with treatment. J Paediatr Child Health 2009, 45:720-726. 10.1111/j.1440-1754.2009.01601.x, 19863710.
9. Albright AL, Barry MJ, Fasick P, Barron W, Shultz B. Continuous intrathecal baclofen infusion for symptomatic generalized dystonia. Neurosurgery 1996, 38:934-939. 10.1097/00006123-199605000-00015, 8727818.
10. Albright AL, Barry MJ, Painter MJ, Shultz B. Infusion of intrathecal baclofen for generalized dystonia in cerebral palsy. J Neurosurg 1998, 88:73-76. 10.3171/jns.1998.88.1.0073, 9420075.
11. Albright AL, Barry MJ, Shafron DH, Ferson SS. Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol 2001, 43:652-657. 10.1017/S0012162201001190, 11665821.
12. World Health Organisation International Classification of Functioning 2001, Geneva: Disability and Health, Ref Type: Catalog, World Health Organisation.
13. Turner-Stokes L. Goal attainment scaling (GAS) in rehabilitation: a practical guide. Clin Rehabil 2009, 23:362-370. 10.1177/0269215508101742, 19179355.
14. Bovend'Eerdt TJH, Botell RE, Wade DT. Writing SMART rehabilitation goals and achieving goal attainment scaling: a practical guide. Clin Rehabil 2009, 23:352-361. 10.1177/0269215508101741, 19237435.
15. Steenbeek D, Ketelaar M, Galama K, Gorter JW. Goal attainment scaling in paediatric rehabilitation: a critical review of the literature. Dev Med Child Neurol 2007, 49:550-556. 10.1111/j.1469-8749.2007.00550.x, 17593130.
16. Steenbeek D, Ketelaar M, Galama K, Gorter JW. Goal attainment scaling in paediatric rehabilitation: a report on the clinical training of an interdisciplinary team. Child: care, health and development 2008, 34:521-529.
17. Steenbeek D, Ketelaar M, Lindeman E, Galama K, Gorter JW. Interrater reliability of goal attainment scaling in rehabilitation of children with cerebral palsy. Arch Phys Med Rehabil 2010, 91:429-435. 10.1016/j.apmr.2009.10.013, 20298835.
18. Choate R, Smith A, Cardillo JE, Thompson L. Training in the use of Goal Attainment Scaling. Community Ment Health J 1981, 17:171-181. 10.1007/BF00754364, 6813019.
19. Steenbeek D, Meester-Delver A, Becher JG, Lankhorst GJ. The effect of botulinum toxin type A treatment of the lower extremity on the level of functional abilities in children with cerebral palsy: evaluation with goal attainment scaling. Clin Rehabil 2005, 19:274-282. 10.1191/0269215505cr859oa, 15859528.
20. Monbaliu E, Ortibus E, De Cat J, Dan B, Heyrman L, Prinzie P, De Cock P, Feys H. The Dyskinesia Impairment Scale: a new instrument to measure dystonia and choreoathetosis in dyskinetic cerebral palsy. Dev Med Child Neurol 2012, 54:278-283. 10.1111/j.1469-8749.2011.04209.x, 22428172.
21. Barry MJ, VanSwearingen JM, Albright AL. Reliability and responsiveness of the Barry-Albright Dystonia scale. Dev Med Child Neurol 1999, 41:404-411. 10.1017/S0012162299000870, 10400175.
22. Hoving MA, van Kranen-Mastenbroek VHJM, van Raak EPM, Spincemaille GHJJ, Hardy ELM, Vles JSH. On behalf of the Dutch Study Group on Child Spasticity. Placebo controlled utility and feasibility study of the H-reflex and flexor reflex in spastic children treated with intrathecal baclofen. Clin Neurophysiol 2006, 117:1508-1517. 10.1016/j.clinph.2006.04.014, 16759902.
23. Bour LJ, Koelman JHTM, van Bruggen GJ, Speelman JD, Ongerboer de Visser BW Soleus H-reflex tests in spasticity and dystonia: A computerized analysis. J Electromyogr Kinesiol 1991, 1:9-19. 10.1016/1050-6411(91)90022-W, 20719591, Ongerboer de Visser BW.
24. Becher JG, Doorenbosch C, Folmer K, Scholtes VAB, Voorman JM, Wolterbeek N. Handleiding standaard lichamelijk onderzoek bij kinderen met een centraal motorische parese 2011, Amsterdam: Reed business.
25. Scholtes VAB, Dallmeijer AJ, Becher JG. The spasticity test: a clinical instrument to measure spasticity in children with cerebral palsy. The effectiveness of multilevel botulinum toxin type A and comprehensive rehabilitation in children with cerebral palsy [dissertation] 2007, Amsterdam: VU University Medical Center.
26. Scholtes VAB, Becher JG, Beelen A, Lankhorst GJ. Clinical assessment of spasticity in children with cerebral palsy: a critical review of available instruments. Dev Med Child Neurol 2006, 48:64-73.
27. Sandella DE, O'Brien LM, Shank LK, Warschausky SA. Sleep and quality of life in children with cerebral palsy. Sleep Med 2011, 12:252-256. 10.1016/j.sleep.2010.07.019, 3065038, 21334973.
28. Bensmail D, Quera Salva MA, Roche N, Benyahia S, Bohic M, Denys P, Bussel B, Lofaso F. Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity. Neurology 2006, 67:1432-1436. 10.1212/01.wnl.0000239827.38036.23, 17060570.
29. Bensmail D, Marquer A, Roche N, Godard A, Lofaso F, Quera Salva MA. Pilot study assessing the impact of intrathecal baclofen administration mode on sleep-related respiratory parameters. Arch Phys Med Rehabil 2012, 93:96-99. 10.1016/j.apmr.2011.08.020, 22200387.
30. Chervin RD, Hedger K, Dillon JI, Pituch KJ. Pediatric Sleep Questionnaire (PSQ): validity and reliability of scales for sleep-disordered breathing, snoring, sleepiness and behavioral problems. Sleep Med 2000, 1:21-32. 10.1016/S1389-9457(99)00009-X, 10733617.
31. Palisano RJ, Hanna SE, Rosenbaum PL, Russel DJ, Walter EP, Raina PS, Galuppi BE. Validation of a model of gross motor function for children with cerebral palsy. Phys Ther 2000, 80:974-985.
32. Wood E, Rosenbaum PL. The gross motor function classification system for cerebral palsy: a study of reliability and stability over time. Dev Med Child Neurol 2000, 42:292-296. 10.1017/S0012162200000529, 10855648.
33. Eliasson AC, Krumlinde-Sundholm L, Rösblad B, Beckung E, Arner M, Ohrvall AM, Rosenbaum PL. The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability. Dev Med Child Neurol 2006, 48:549-554. 10.1017/S0012162206001162, 16780622.
34. Morris C, Kurinczuk JJ, Fitzpatrick R, Rosenbaum PL. Reliability of the manual ability classification system for children with cerebral palsy. Dev Med Child Neurol 2006, 48:950-953. 10.1017/S001216220600209X, 17109781.
35. Voorman JM, Dallmeijer AJ, van Eck M, Schuengel C, Becher JG. Social functioning and communication in children with cerebral palsy: association with disease characteristics and personal and environmental factors. Dev Med Child Neurol 2009, 52:441-447. 10.1111/j.1469-8749.2009.03399.x, 19811523.
36. Geytenbeek JJM, Heim MMJ, Vermeulen RJ, Oostrom KJ. Assessing comprehension of spoken language in nonspeaking children with cerebral palsy: application of a newly developed computer based instrument. Augment Altern Commun 2010, 26:97-107. 10.3109/07434618.2010.482445, 20497073.
37. Feldman AB, Haley SM, Coryell J. Concurrent and construct validity of the Pediatric Evaluation of Disability Inventory. Phys Ther 1990, 70:602-610.
38. Haley SM, Coster WJ, Ludlow LH, Haltiwanger JT, Andrellos PJ. Pediatric Evaluation of Disability Inventory (PEDI): development, standardization and administration manual 1992, Boston, MA: PEDI Research Group, Department of Rehabilitation Medicine.